NCT05646043

Brief Summary

The pilot research project is focused on the feasibility of a prehabilitation program for two groups of diagnoses (esophageal and stomach cancer, rectal cancer).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2022

Completed
16 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 18, 2024

Status Verified

January 1, 2024

Enrollment Period

2.9 years

First QC Date

November 15, 2022

Last Update Submit

January 17, 2024

Conditions

Keywords

prehabilitationcancer of the digestive systemcancer of the rectumendurance walkingpower training

Outcome Measures

Primary Outcomes (3)

  • Number of enrolled patients

    The number of patients who express an interest in being included in the study from all patients diagnosed and indicated for neoadjuvant therapy in the monitored period. the reasons for refusal to enroll in the study will be monitored.

    3 months

  • Number of patients completing the program

    The number of patients who complete the prehabilitation program by the time of surgery.

    3 months

  • Individual patient compliance

    Number of days when the patient wore the smart bracelet and performed or attempted to perform the exercise program out of the total number of days in the monitored period

    3 months

Secondary Outcomes (19)

  • Changes in spirometry examination results

    3 months

  • Changes in the quality of life

    3 months

  • Parameters monitored by the oncologist

    3 months

  • Exercise program - number of steps/day

    3 months

  • Exercise program - pressing force on the dynamometer

    3 months

  • +14 more secondary outcomes

Study Arms (2)

Patients with cancer of the digestive system

ACTIVE COMPARATOR

Patients with cancer of the digestive system (oesophageal and stomach cancer) will be enrolled in this study arm.

Behavioral: Physical trainingBehavioral: Muscle strength training

Patients with cancer of the rectum

ACTIVE COMPARATOR

Patients with cancer of the rectum will be enrolled in this study arm.

Behavioral: Physical trainingBehavioral: Muscle strength training

Interventions

Physical training consists of endurance walking and strength training. The basis for determining the number of steps per day is the baseline value of each patient. This will increase by 10-15% every week until the surgery date. The assumption of a total load increase is 120-180% compared to the baseline.

Patients with cancer of the digestive systemPatients with cancer of the rectum

Muscle strength training will take place using exercises to strengthen the upper and lower limbs and to strengthen the trunk. There will be a set of 5 exercises in two difficulty variants. The study subjects will perform this set 7 days a week, and will repeat the assembly a total of two times. The total time of strength training is 10 min.

Patients with cancer of the digestive systemPatients with cancer of the rectum

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • radically operable locally advanced cancer of the esophagus, esophagogastric junction, stomach
  • radically operable locally advanced carcinoma of the rectum
  • the patient is able to handle the planned surgical resection procedure
  • planned preoperative neoadjuvant therapy
  • age \> 18 years
  • the ability to complete a spiroergometric examination
  • the ability to carry out a prehabilitation program consent to participate in the study confirmed by signing the informed consent

You may not qualify if:

  • contraindications for spiroergometric examination
  • limitation on the part of the locomotor system to spiroergometric examination or daily exercise (e.g. amputation, severe gonarthrosis, coxarthrosis)
  • inoperability determined by the interdisciplinary team
  • inability to manage the planned operational performance
  • acute surgical performance
  • synchronous malignant disease
  • multivisceral resection
  • planned non-surgical therapeutic procedure
  • incomplete data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 708 52, Czechia

RECRUITING

Related Publications (1)

  • Chmelova I, Pastucha D, Hudecek T, Guran Z, Ciecotkova S, Martinek L, Zubikova J, Matlova A, Dolezel J, Salounova D, Chmelo J. Prehabilitation during neoadjuvant therapy in patients with cancer of the upper gastrointestinal tract and rectum-the study protocol. Front Sports Act Living. 2025 Feb 3;6:1495398. doi: 10.3389/fspor.2024.1495398. eCollection 2024.

MeSH Terms

Conditions

Digestive System NeoplasmsRectal Neoplasms

Interventions

Physical Conditioning, Human

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsDigestive System DiseasesColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

ExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Irina Chmelová, MD,PhD,MBA

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jiří Hynčica

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
No masking is used in this study.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study subjects will be enrolled in two parallel groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2022

First Posted

December 12, 2022

Study Start

December 1, 2022

Primary Completion

November 1, 2025

Study Completion

December 1, 2025

Last Updated

January 18, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers. The data may be provided upon request.

Locations